Adcentrx Therapeutics logo

Adcentrx Therapeutics

Merging Chemistry and Biology to Benefit the Lives of Patients

27 employees · est. 2021 · San Diego, United States

VS
Synnovation Therapeutics logo

Synnovation Therapeutics

A precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers

52 employees · est. 2021 · Wilmington, United States

Synnovation Therapeutics is the larger of the two.

Side-by-Side Comparison

Adcentrx Therapeutics Synnovation Therapeutics
Founded
2021 2021
Headquarters
San Diego, United States Wilmington, United States
Employees
27 52 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Life Sciences
Funding Stage
Series A Series A
Total Funding
$101.00M $139.00M
Funding Rounds
3 3
Services
Development of protein conjugate therapeutics, Targeted cancer therapies, Clinical trials for cancer and life-threatening diseases Discovery and development of targeted medicines, Building novel small molecule therapies, Advancing therapies into clinical trials
Target Customers
Patients with cancer and life-threatening diseases, Healthcare providers, Medical researchers Patients with specific therapeutic needs, Healthcare providers, Medical research institutions
Taxonomy
Protein Conjugates, Therapeutic Development, Cancer Treatment, Targeted Therapies, Precision Medicine, Biologics, Small Molecule Payloads, Life-threatening Diseases, Next-generation Therapeutics, Patient Treatment Options, Disease Fighting Precision Oncology, Small Molecule Therapies, Cancer Biology, Medicinal Chemistry, Targeted Therapies, Pharmacology, Cancer Care, Drug Discovery, Clinical Trials, Therapeutics Development, Novel Therapies, Patient-Focused Medicine, In Vivo Pharmacology, Cellular Assays, Biochemical Assays
Website
adcentrx.com synnovationtx.com
Adcentrx Therapeutics logo

About Adcentrx Therapeutics

Adcentrx Therapeutics, a biotechnology company founded in 2021, is making significant strides in the realm of protein conjugate therapeutic development. With a focus on addressing cancer and other critical illnesses, their unique approach leverages the precision of biologics combined with the potent...

Synnovation Therapeutics logo

About Synnovation Therapeutics

Synnovation Therapeutics, founded in 2021, is a rising player in the Biotechnology sector, with a particular focus on Health Care and Life Sciences. Headquartered in the United States, the company is carving a niche in precision oncology by developing small molecule therapies optimized to target key...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Adcentrx Therapeutics and Synnovation Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Adcentrx Therapeutics and Synnovation Therapeuti... — by email.

Frequently Asked Questions

Adcentrx Therapeutics — Merging Chemistry and Biology to Benefit the Lives of Patients. Synnovation Therapeutics — A precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Adcentrx Therapeutics has raised $101.00M while Synnovation Therapeutics has raised $139.00M.
Adcentrx Therapeutics and Synnovation Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Adcentrx Therapeutics with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy